The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Risk for Fracture in Women with Low Serum Levels of Thyroid-Stimulating Hormone
Abstract
BACKGROUND: Biochemical evidence of hyperthyroidism may be associated with low bone mass, particularly in older postmenopausal women, but no prospective studies of thyroid function and subsequent fracture risk have been done. OBJECTIVE: To examine the association between low levels of thyroid-stimulating hormone (TSH) and fracture in older women. DESIGN: Prospective cohort study with case-cohort sampling. SETTING: Four clinical centers in the United States. PATIENTS: 686 women older than 65 years of age from a cohort of 9704 women recruited from population-based listings between 1986 and 1988. MEASUREMENTS: Baseline assessment of calcaneal bone mass, spine radiography, and history of thyroid disease. Spine radiography was repeated after a mean follow-up of 3.7 years; nonspine fractures were centrally adjudicated. Thyroid-stimulating hormone was measured in sera obtained at baseline from 148 women with new hip fractures, 149 women with new vertebral fractures, and a subsample of 398 women randomly selected from the cohort. RESULTS: After adjustment for age, history of previous hyperthyroidism, self-rated health, and use of estrogen and thyroid hormone, women with a low TSH level (0.1 mU/L) had a threefold increased risk for hip fracture (relative hazard, 3.6 [95% CI, 1.0 to 12.9]) and a fourfold increased risk for vertebral fracture (odds ratio, 4.5 [CI, 1.3 to 15.6]) compared with women who had normal TSH levels (0.5 to 5.5 mU/L). After adjustment for TSH level, a history of hyperthyroidism was associated with a twofold increase in hip fracture (relative hazard, 2.2 [CI, 1.0 to 4.4]), but use of thyroid hormone itself was not associated with increased risk for hip fracture (relative hazard, 0.5 [CI, 0.2 to 1.3]). CONCLUSIONS: Women older than 65 years of age who have low serum TSH levels, indicating physiologic hyperthyroidism, are at increased risk for new hip and vertebral fractures. Use of thyroid hormone itself does not increase risk for fracture if TSH levels are normal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Conflicting results have also been reported regarding the risk of fractures [63,105,106] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [105]
In the citing paper
“If TH levels are elevated in the long term, patients will have a higher risk of atrial fibrillation, osteoporosis, and fracture (169, 170).”
From Levothyroxine: conventional and novel drug delivery formulations. (2023) · cites this paper as [169]
In the citing paper
“Evidence in the clinical literature suggests that there is an increased risk of bone fracture in individuals who are exposed to supratherapeutic doses of exogenous thyroid hormone for extended periods of time.”
From Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report (2017) · cites this paper as [96]
In the citing paper
“Increased bone loss and risk of fracture was also found in euthyroid postmenopausal women with fT4 and/or fT3 levels within the upper normal range and in older adults with low TSH (104–106).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [105]
In the citing paper
“A number of population-based studies have reported that certain groups of subjects with SH have increased fracture rates, including all adults (407), postmenopausal women (408), men (409), or subjects who progress to overt hyperthyroidism over time (391).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [408]
In the citing paper
“Some of these studies re-ported increased risks of overall mortality in older subjects (380,429), cardiovascular events (391), heart failure (381), and atrial fibrillation in all subjects (401) or in older subjects (384), and vertebral fractures in older women (408).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [408]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Self-citationPerspective how many women have osteoporosis?
Melton, L. J., Chrischilles, E. A., Cooper, C. C., Lane, A. W., & Riggs, B. L. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070902 · Cited by 1,400
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259 · cited 1×
“1 mIU/L or less are highly correlated with a diminished response to thyroidreleasing hormone stimulation (33) and are associated with an increased incidence of atrial fibrillation (34).”
BackgroundMarkers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
Garnero, P., Hausherr, E., Chapuy, M. C., Marcelli, C., Grandjean, H., Müller, C., Cormier, C., Bréart, G., Meunier, P. J., & Delmas, P. D. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111021 · Cited by 984
Nevitt, M. C., Ettinger, B., Black, D. M., Stone, K. L., Jamal, S. A., Ensrud, K. E., Segal, M. R., Genant, H. K., & Cummings, S. R. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-10-199805150-00001 · Cited by 841
Self-citationHow Many Women Have Osteoporosis?
Melton, L. J., Chrischilles, E. A., Cooper, C., Lane, A. W., & Riggs, B. L. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2005.20.5.886 · Cited by 708
Analysis of Case-Cohort Designs
Barlow, W. E., Ichikawa, L., Rosner, D., & Izumi, S. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00102-x · Cited by 682
Endogenous Hormones and the Risk of Hip and Vertebral Fractures among Older Women
Cummings, S. R., Browner, W. S., Bauer, D. C., Stone, K. L., Ensrud, K. E., Jamal, S. A., & Ettinger, B. B. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809103391104 · Cited by 660
Self-citationGenant, H. K., Jergas, M. D., Palermo, L., Nevitt, M. C., Valentin, R. S., Black, D. M., & Cummings, S. R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110716 · Cited by 637
Self-citationFactors Associated with Appendicular Bone Mass in Older Women
Bauer, D. C., Browner, W. S., Cauley, J. A., ORWOLL, E. S., Scott, J. C., Black, D. M., Tao, J. L., & Cummings, S. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-9-199305010-00001 · Cited by 563
Self-citation
Research works printed but not linked: 7
- 10.1001/jama.1989.03420180077034 · DOI · Paper page
- Auwerx J, 1986, Q J Med, 60, 737
- 10.1001/archinte.1995.00430110024003 · DOI
- Spencer CA, 1993, J Clin Endocrinol Metab, 76, 494
- Bauer DC, 1997, J Clin Endocrinol Metab, 82, 2931
- Cummings S, 1996, J Bone Miner Res, 11, S128
- Seppel T, 1996, J Clin Endocrinol Metab, 81, 1663
Cited by
Sorted by citations
Items 301–400 of 467
Osteoporose – aktuelle Diagnostik und Therapie
Pfeilschifter, J. (2009) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-009-1135-2 · Cited by 5
Does TSH concentration influence skeletal health?
Bauer, D. C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.59 · Cited by 5
Self-citationSubclinical hypothyroidism and subclinical hyperthyroidism
Fatourechi, V. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.2 · Cited by 5
Die Rolle des Labors in der Diagnostik und Verlaufskontrolle der Osteoporose
KRAENZLIN, M. E., Anliker, M., & Griesmacher, A. (2008) · Therapeutische Umschau · doi:10.1024/0040-5930.65.9.513 · Cited by 5
Paradigm Shift in the Pathophysiology of Postmenopausal and Thyrotoxic Osteoporosis
Zaidi, M., Iqbal, J. Z., Blair, H. C., Zallone, A. Z., Davies, T. F., & Sun, L. (2009) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20136 · Cited by 5
Pater, A., Nowacki, W., & Sypniewska, G. (2011) · PubMed Central · Cited by 5
Thyroid Disorders and Bone Mineral Homeostasis
Feigerlová, E., Klein, M., Angelousi, A. G., Groza, L., Leheup, B., & Weryh, G. (2012) · InTech eBooks · doi:10.5772/46207 · Cited by 5
Zeni, S. N., Acotto, C. G., & Mautalén, C. (2001) · Calcified Tissue International · doi:10.1007/s00223-001-1005-2 · Cited by 5
Clinical Utility of Sensitive TSH Measurements
Witherspoon, L. R. (2005) · Laboratory Medicine · doi:10.1309/60uvgc5u8q69ut1g · Cited by 5
An update on subclinical hypothyroidism and subclinical hyperthyroidism
Fatourechi, M. M., & Fatourechi, V. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.887433 · Cited by 5
Enfermedad tiroidea subclínica: revisión y enfoque clínico
Liberman, G. C. (2013) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(13)70219-0 · Cited by 7
Liu, C., Sun, M., Zhao, Z., Yang, Y., Yang, Y., Zhao, Y., Zhang, R., Du, X., Liu, X., Ran, S., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1786776 · Cited by 8
Zhou, R.-Y., Li, N., Tan, H., Tang, N., Chen, P., Liu, M., Ouyang, D., Qin, Z.-E., Ai, L., Wei, B., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1126592 · Cited by 4
Karagül, S., & Kartaloğlu, I. F. (2023) · Turkish Journal of Osteoporosis · doi:10.4274/tod.galenos.2023.31932 · Cited by 4
Reverter, J. L., & Colomé, E. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/s2173-5093(11)70013-7 · Cited by 4
Reyes‐García, R., Gimeno, E. J., Martín, A. G., Muñoz, M. R., Sáez, J. M. G., Fernández, I. L., Varsavsky, M., Iglesias, S. G., Rodríguez, I. C., Ballesteros-Pomar, M. D., et al. (2012) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.01.004 · Cited by 4
Subclinical Thyroid Disease: Time to Enter the Age of Evidence-Based Medicine
Goichot, B., & Pearce, S. H. S. (2012) · Thyroid · doi:10.1089/thy.2012.2208.com · Cited by 4
Brown, R. S. (2009) · CRC Press eBooks · doi:10.3109/9781420070651-9 · Cited by 4
Boruah, P. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/19750.8441 · Cited by 4
Effects of Thyroid Stimulating Hormone on Bone Metabolism
Cho, S. W. (2016) · International Journal of Thyroidology · doi:10.11106/ijt.2016.9.2.127 · Cited by 4
Skeletal Effects of Thyroid Hormones
Bakos, B., Takács, I., Stern, P. H., & Lakatos, P. L. (2018) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-018-9246-z · Cited by 4
Litwic, A., Dębska-Ślizień, A. M., & Dennison, E. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-78128-6_11 · Cited by 4
Levothyroxine personalized treatment: is it still a dream?
Cappelli, C., Gatta, E., & Ippolito, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1334292 · Cited by 6
Treatment of Hypothyroidism and Stress Using Neuro-Emotional Technique (NET): A Case Study
Bablis, P., Day, R. R., Bablis, S., & Pollard, H. P. (2024) · Cureus · doi:10.7759/cureus.58231 · Cited by 6
Hipotiroidismo e hipertiroidismo subclínicos en el anciano
Robles, F., Sanz, F., Ascensión, M., & López-Arrieta, J. M. (2003) · Revista Española de Geriatría y Gerontología · doi:10.1016/s0211-139x(03)74866-5 · Cited by 4
New Horizons in Skeletal Physiology and Pathophysiology
Zaidi, M., Iqbal, J. Z., & Sun, L. (2010) · Endocrine Practice · doi:10.4158/ep10118.ra · Cited by 4
Endogenous subclinical hyperthyroidism: who, when and why to treat
Biondi, B. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.69 · Cited by 4
Zaidi, M., Yuen, T., Sun, L., Davies, T. F., Zallone, A. Z., & Blair, H. C. (2013) · Primer on the metabolic bone diseases and disorders of mineral metabolism · doi:10.1002/9781118453926.ch116 · Cited by 4
Gouveia, C. H. D. A., Capelo, L. P., Neofiti-Papi, B., & Zallone, A. Z. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11227-9 · Cited by 4
Emkey, G. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65820-8 · Cited by 4
Emkey, G. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00039-x · Cited by 4
Pathophysiology, diagnosis and management of secondary osteoporosis
Paccou, J., Tsourdi, E. A., Anastasilakis, A. D., Lems, W. F., & Compston, J. E. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01252-x · Cited by 4
Beshyah, S., Bashir, M., Hafidh, K., Afandi, B. O., Shaikh, S. S., Hammami, S. O., & Khalil, A. (2024) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0044-1789211 · Cited by 3
Carceller, D. B., Segundo, P. L., Beltrán, P. N., París, A. S., Hernández, P. D. C., Villanueva, M. M., & Olivares, D. A. (2011) · Revista Española de Medicina Nuclear · doi:10.1016/j.remn.2011.01.004 · Cited by 3
Coco-Martín, M. B., Vega, L. L., Blázquez-Cabrera, J. A., Navarro, A., Moro, M. J., Arranz-García, F., Amérigo, M. J., Henríquez, M. S., Vázquez, M. Á., Montoya-García, M.-J., et al. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03544-x · Cited by 3
Optimisation of thyroid hormone replacement using an automated thyroid register
Cuthbertson, D. J., Flynn, R. W. V., Jung, R. T., & Leese, G. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2006.00940.x · Cited by 3
Clinical Implications and Management of Sub Clinical Hyperthyroidism: A Review
De, P., Pang, T., & Das, G. C. (2012) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2012.23004 · Cited by 3
Winkler, A., Mueller, B., & Diem, P. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450667 · Cited by 3
Safi, S., Hassikou, H., Hadri, L., Sbihi, A., & Kadiri, A. (2006) · Annales d Endocrinologie · doi:10.1016/s0003-4266(06)72536-7 · Cited by 3
Influence of thyroid hormones on bone density
Begić, A., Begić, A., & Arnautović-Halimić, A. (2019) · Medicinski Glasnik · doi:10.17392/1056-20 · Cited by 3
Wémeau, J.-L., Cardot-Bauters, C., d'Herbomez-Boidein, M., Perimenis, P., & Cephise-Velayoudom, F. L. (2006) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(06)41940-5 · Cited by 4
Structural and Metabolic Assessment of Bone
Narla, R. R., & Ott, S. M. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_376 · Cited by 4
[Uncertainties about the benefit of treatment in subclinical thyroid dysfunction].
Wiersinga, W. M. (2006) · PubMed · Cited by 4
Other Secondary Causes of Osteoporosis
Hamdy, N. A. T., & Appelman‐Dijkstra, N. M. (2018) · Primer on the metabolic bone diseases and disorders of mineral metabolism · doi:10.1002/9781119266594.ch66 · Cited by 3
Alves-Silva, E. G., Ribeiro, B. F., Silva, C. F., de Kássia-Alves, R., Arruda‐Vasconcelos, R., Louzada, L. M., de Almeida-Gomes, R. F., Santos, J. M., & Gomes, B. P. F. D. A. (2025) · Bioengineering · doi:10.3390/bioengineering12070746 · Cited by 2
Zhang, T., Pan, W., Huang, K., Qiu, J., Zhang, W., & Yang, J. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2558122 · Cited by 2
Zheng, H., Lai, V., Lu, J., Hu, D., Kang, J. K., Burman, K. D., Wartofsky, L., & Rosen, J. E. (2022) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2022.11.025 · Cited by 2
Association Between Papillary Thyroid Carcinoma and Vertebral Fracture
Otani, H., Notsu, M., Yamauchi, M., Nawata, K., & Kanasaki, K. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2059-8830 · Cited by 2
Hanmayyagari, B. (2020) · IAR Journal of Medicine and Surgery Research · doi:10.47310/iarjmsr.2020.v01i01.07 · Cited by 2
Zhang, L., Ma, C., Yin, X., Zhang, F., Fang, X., Zhang, C., Shang, L., & Ma, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-00448-x · Cited by 2
Simintiriadis, D., Bondeson, A., Bondeson, L., Svensson, J., & Almqvist, E. G. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2012.733409 · Cited by 2
What Is the Clinical Importance of Subclinical Hyperthyroidism?
Burman, K. D. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.1114 · Cited by 2
TSH and Thyroid Hormones Both Regulate Bone Mass
Sun, L., Liu, X., Zhu, L.-L., Liu, J. H., Liu, Q. C., Iqbal, J. Z., Mechanick, J. I., Davies, T. F., & Zaidi, M. (2008) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9024-z · Cited by 2
Long-Term Effect of Prolonged TSH Suppression on the Skeletal System
Kim, M. H., & Kang, M. I. (2012) · Journal of Korean Thyroid Association · doi:10.11106/jkta.2012.5.1.31 · Cited by 2
[Subclinical thyroid dysfunction. Diagnostic and therapeutic considerations].
Ramos, D., & Pérez-Enríquez, B. (2006) · PubMed · Cited by 3
Thyroid Dysfunction Does Not Affect the Bone Mineral Density in Postmenopausal Women
Keskin, H. L., Üstüner, İ., Avşar, A. F., DENİZ, H. C., Secen, E. İ., & Yeğin, G. F. (2014) · The Annals of Clinical and Analytical Medicine · doi:10.4328/jcam.1197 · Cited by 2
Hemodialysis Patients with Incidental Hypothyroidism -The Approach to L-thyroxine
Wu, Y. Y. N. S. C. (2013) · Journal of Thyroid Disorders & Therapy · doi:10.4172/2167-7948.1000138 · Cited by 1
McDermott, M., & Ridgway, E. C. (2009) · CRC Press eBooks · doi:10.3109/9781420070651-5 · Cited by 2
Pituitary Hormone-Driven Mechanism for Skeletal Loss
Yuen, T., Sun, L., Abu‐Amer, W., Liu, P., Davies, T. F., Blair, H. C., New, M. I., Zallone, A. Z., & Zaidi, M. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-56192-9_10 · Cited by 2
Thyroid Hormone in Bone and Joint Disorders
Bassett, J. H. D., & Williams, G. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00031-9 · Cited by 2
Actualités dans la prise en charge des cancers thyroïdiens de souche vésiculaire
Payrat, J. A.-D., Caron, P. J., & Borson‐Chazot, F. (2014) · Annales d Endocrinologie · doi:10.1016/s0003-4266(14)70022-8 · Cited by 2
Alteraciones metabólicas óseas en las enfermedades endocrinológicas
Diaz‐Guerra, G. M., Gimeno, E. J., Mira, S. A., & Carranza, F. H. (2002) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(02)70841-x · Cited by 2
Effects of Abnormal Thyroid Function Status to Bone Metabolism
Ahn, H. Y. (2018) · International Journal of Thyroidology · doi:10.11106/ijt.2018.11.1.21 · Cited by 2
Thyroid suppression therapy: risks and indications
Steward, D., Falciglia, M., & Kim, P. S. (2002) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/00020840-200206000-00007 · Cited by 2
Busaidy, N. L., & Kloos, R. T. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4745-2.00026-2 · Cited by 2
Postmenopausale und kortikoidinduzierte Osteoporose: Leitliniengerechte Prophylaxe und Therapie
Pfeilschifter, J. (2005) · Der Internist · Cited by 2
Variation in 'normal' thyroid function—effect on bone health?
Cooper, M. S. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.132 · Cited by 1
Subclinical Thyroid Dysfunction in the Elderly
Ko, K. D. (2014) · Journal of the Korean Geriatrics Society · doi:10.4235/jkgs.2014.18.3.111 · Cited by 1
Osteoporosis secundaria: diabetes mellitus e hipertiroidismo
Muñoz‐Torres, M., Varsavsky, M., Martín, A. G., & Escobar‐Jiménez, F. (2010) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(10)70176-1 · Cited by 1
Diagnosis and Management of Hyperthyroidism in Older Adults
Rehman, S. U., Johnson, R. H., Basile, J., & Hutchison, F. N. (2006) · Cited by 1
Thyroid Cancer 1 Controversies in primary treatment of low-risk papillary thyroid cancer
McLeod, D. S. A., Sawka, A. M., & Cooper, D. S. (2013) · Cited by 1
Subclinical Thyroid Disorders: Clinical Significance and When to Treat?
Ng, M. C. W., Loo, Y. X., & Poon, Z. M. (2014) · Proceedings of Singapore Healthcare · doi:10.1177/201010581402300308 · Cited by 1
TSH Suppression after Differentiated Thyroid Cancer Surgery and Osteoporosis
Park, K. S. (2016) · The Korean Journal of Endocrine Surgery · doi:10.16956/kaes.2016.16.1.1 · Cited by 1
Hormone Actions in the Regulation of Calcium and Phosphorus Metabolism
Ontjes, D. A. (2011) · CRC Press eBooks · doi:10.1201/b11228-8 · Cited by 1
Thyroid Disease in the Elderly
Cappola, A. R., Miller, M., & Gambert, S. R. (2009) · CRC Press eBooks · doi:10.3109/9781420070651-11 · Cited by 1
Advances in Our Understanding of Hyperthyroidism-associated Bone Loss
Brassill, M. J., & Williams, G. R. (2008) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2008.04.02.103 · Cited by 1
Subkliniczna dysfunkcja tarczycy – czy i kiedy leczyć?
Kuliczkowska-Płaksej, J., Tupikowska, M., Zatońska, K., & Bednarek-Tupikowska, G. (2013) · Family Medicine & Primary Care Review · Cited by 1
Patología tiroidea en atención primaria
González, A. L., Vázquez, Á. N., Carballido, F. C., Gómez, N. G., Rodríguez, M. L., & Carro, M. C. (2016) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2015.12.012 · Cited by 1
Metabolism and mineral one density in thyrotoxicosis (literature review)
Shymon, V. M., & Stojka, V. (2017) · ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS · doi:10.15674/0030-598720171113-117
Subclinical thyrotoxicosis and bone
Doga, M., Formenti, A. M., Frara, S., Memo, M., Giustina, A., & Mazziotti, G. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2018.03.002 · Cited by 1
Pearce, S. H. S. (2022) · doi:10.1093/med/9780198870197.003.0057 · Cited by 1
Differentiated Thyroid Carcinoma
Sipos, J. A., & Mazzaferri, E. L. (2009) · CRC Press eBooks · doi:10.3109/9781420070651-7 · Cited by 1
Franklyn, J. A. (2013) · Medicine · doi:10.1016/j.mpmed.2013.06.003 · Cited by 1
Chen, J., Hu, L., Li, N., Deng, W., Xu, X., Wang, L., Zhao, K., Lu, S., Liu, X., Cheng, X., et al. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00841-9 · Cited by 1
Jeon, Y. K., Kim, D., Kim, M., Kim, B. H., Pak, K., Kim, J., & Keun-young Kim, A. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01800-4 · Cited by 1
Thyroid Function in Healthy Ageing and Longevity
Aggarwal, N., & Razvi, S. (2017) · Healthy ageing and longevity · doi:10.1007/978-3-319-63001-4_6 · Cited by 1
Poudel, P., Chalasani, R., Goonathilake, M. R., Waqar, S., George, S., Jean-Baptiste, W., Ali, A. Y., Inyang, B., Koshy, F. S., George, K., et al. (2022) · Cureus · doi:10.7759/cureus.26353 · Cited by 1
Carceller, D. B., Segundo, P. L., Beltrán, P. N., París, A. S., Hernández, P. D. C., Villanueva, M. M., & Olivares, D. A. (2011) · Revista Española de Medicina Nuclear · doi:10.1016/s1578-200x(11)70021-3 · Cited by 1
Iatrogenic Hypothyroidism and Its Sequelae
Vitti, P., & Latrofa, F. (2012) · doi:10.1002/9781118444832.ch32 · Cited by 1
Disfunción tiroidea subclínica en el anciano
Copín, C. P., & Agudo, F. R. (2003) · Medicina de Familia SEMERGEN · doi:10.1016/s1138-3593(03)74252-x · Cited by 1
Suivi au long cours du traitement freinateur des cancers thyroïdiens différenciés
Massart, C. (2011) · Médecine Nucléaire · doi:10.1016/j.mednuc.2011.11.008 · Cited by 1
Thyroid Hormone and the Skeleton
Baran, D. T. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50050-1 · Cited by 1
ERKRANKUNGEN DER ENDOKRINEN ORGANE UND DES STOFFWECHSELS
Jung, N., Mayet, W.-J., Mertens, P. R., Meyer, J. S., Müller, O.-A., Pfeifer, M., Schellinger, P. D., Weiss, N., & Wendtner, C.-M. (2020) · Elsevier eBooks · doi:10.1016/b978-3-437-06282-7.50015-2 · Cited by 1
Sarkar, S. D. (2006) · Springer eBooks · doi:10.1007/978-3-540-47953-6_7 · Cited by 1
El hueso en el hipertiroidismo
Gimeno, E. J., & Berdonces, M. C. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00006-x
Thyroid Hormone Replacement Therapy for Primary and Secondary Hypothyroidism
Cooper, D. S. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-375-0_7
Bone mass and fractures in patients at risk for secondary osteoporosis
Heijckmann, A. C. (2007) · Research Publications (Maastricht University) · doi:10.26481/dis.20071219ah
Secondary Causes of Osteoporosis: Bone Diseases
Ebeling, P. R. (2013) · doi:10.1002/9781118316290.ch5
Cormier, C. (2011) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(11)51199-0
The Incidence of Thyroid Dysfunction in the Adult Health Examinees in Kutchan Kosei General Hospital
KAWASAKI, K., Beniko, M., & Mashio, Y. (2009) · JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE · doi:10.2185/jjrm.58.63
Metadata
- Authors
- Bauer, D. C., Ettinger, B., Nevitt, M. C., Stone, K. L., & for the Study of Osteoporotic Fractures Research Group
- Affiliations
- University of Minnesota (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2001-04-03
- Volume
- 134
- Issue
- 7
- Pages
- 561-568
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1992692011
- Cited by
- 467
- References
- 53
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 9 · 2023: 16 · 2022: 15 · 2021: 17 · 2020: 15 · 2019: 12 · 2018: 22 · 2017: 19 · 2016: 23 · 2015: 16 · 2014: 30 · 2013: 23 · 2012: 35
- FWCI
- 14.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08ag000629-03)
- National Institute on Aging (K08-AG-00629)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- thyroid-stimulating hormone, fracture risk, hyperthyroidism, hip fracture, vertebral fractures, postmenopausal women, older women, bone mass, thyroid hormone replacement, osteoporosis
- MeSH terms
- Aged, Follow-Up Studies, Hip Fractures, Humans, Hyperthyroidism, Male, Prospective Studies, Risk Factors, Thyroid Hormones, Thyrotropin, Bone Density, Estrogen Replacement Therapy, Case-Control Studies, Spinal Fractures, Postmenopause, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
